RankAlpha logo
Back to Rankings

APGE

Apogee TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
APGE vs peer average
40/100
APGE vs. peer average (C vs. B)
Grade spread
A 2 · B 4 · C 2 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

LLY is the first available peer comparator.

Eli Lilly is a direct AD peer through Ebglyss; checked coverage framed Apogee's March efficacy update as aiming for comparable efficacy with less frequent dosing versus Ebglyss and Dupixent.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLLYEli Lilly and
APGE
Apogee Therapeutics
LLY
Eli Lilly and
Grade
C
A
Momentum
60
83
Value
41
59
Sentiment
56
55
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs LLY

APGE / LLY
Grade Position
Below peers
APGE vs. peer average (C vs. B)
40/100
Momentum
60
LLY
Value
41
LLY
Sentiment
56
APGE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs APGE
1
LLY
LLY
A
100/100
-2
2
REGN
REGN
C
60/100
Even
3
PTGX
Protagonist Therapeutics Inc Common
B
80/100
-1
4
KYMR
Kymera Therapeutics Inc Common
C
60/100
Even
5
SYRE
Spyre Therapeutics Inc Common
B
80/100
-1
LLY is the first peer returned for this comparison set.